Ongoing and Upcoming Initiatives to Address Opioid Crisis Detailed by DOJ Officials; Changes to Quotas and Other Rules Possible

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Policy

Ongoing and Upcoming Initiatives to Address Opioid Crisis Detailed by DOJ Officials; Changes to Quotas and Other Rules Possible

Joan Flynn

March 5, 2018 at 03:00:00 ET

Attorney General Jeff Sessions on March 1 directed the Drug Enforcement Administration to evaluate whether it should amend its rules governing aggregate production quotas for manufacture of opioids and other Schedule I and II controlled substances. The action was one of several announced by Sessions in Washington, D.C., and also by Deputy Attorney General Rod Rosenstein, who spo... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Ongoing and Upcoming Initiatives to Address Opioid Crisis Detailed by DOJ Officials; Changes to Quotas and Other Rules Possible

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT